Sandbox 1666
From Proteopedia
(Difference between revisions)
Line 10: | Line 10: | ||
Since Beta-Lactam antibiotics are used very often in antimicrobial therapy to treat bacterial infections, bacterial resistance often ocurrs. This enzyme, CTX-M Beta-Lactamase, inhibits the drug's function by breaking apart the lactam ring, making it harder to treat. This is a problem because if we can understand it better, we can change the way we treat to fight off the bacteria better. | Since Beta-Lactam antibiotics are used very often in antimicrobial therapy to treat bacterial infections, bacterial resistance often ocurrs. This enzyme, CTX-M Beta-Lactamase, inhibits the drug's function by breaking apart the lactam ring, making it harder to treat. This is a problem because if we can understand it better, we can change the way we treat to fight off the bacteria better. | ||
+ | There have been several inhibitor-resistant variants that mutations have risen from. More specifically one of them being K234R. This mutation causes a 1500-fold decrease in the cefotaxime and a 5-fold increase in the Kcat for ampicillin. This makes it become a good penicillinase, but a poor cephalosporinase due to slow acylation. The mutation of this will lead to the enzyme being inactivated, making the drug resistance not work efficiently. | ||
The research of this protein is very significant because it has a direct clinical application. | The research of this protein is very significant because it has a direct clinical application. | ||
Line 24: | Line 25: | ||
== Other Important Features == | == Other Important Features == | ||
- | + | <scene name='88/880343/Lys73/1'>Lys73</scene> is another very important amino acid of this CTX-M Beta-Lactamase. Lys73 interacts with the ligand through hydrogen bonds. It is used to lower the pka value of the hydroxyl group. | |
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> |
Revision as of 21:40, 18 April 2021
CTX-M Beta-Lactamase
CTX-M Beta Lactamase is a class a enzyme. This enzyme creates drug resistance to ampicillin and cefotaxime through a two step process: deacylation and acylation.
|